Nephron Information Center News Center

Last updated June 06, 2006 02:04:13 GMT.

Top Stories

• Nephron Info Center creates interactive form for evacuees
• DaVita announces disaster hotline is 1-800-400-8331
• Comics helps patients prepare to hurricane
• COMING SOON: KIDNEYRECIPES.COM
• Nephron Information Center announces disaster ready website for handhelds

• Fighting Cancer with "Cocktails"
  
• Exercises reduce need for asthma inhaler
  
• Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise.
  
• MIV Therapeutics' Breakthrough Vascular Stent Coating Technology Receives Key Independent Endorsement in New Scientific Study; Independent Research Confirms Primary Safety and Biocompatibility Attributes of Company's Patented HAp Coatings
  
• Transgenic drug gets the go-ahead in Europe
  
• Green research base to be built in Antarctic
  
• Medtronic official asks doctors to speak up on Medicare cuts
  
• Keryx Says 43% Of Patients Enrolled In Phase 2 Trial Of Perifosine ...
  
• National Kidney Foundation Position on Payment for Organ Donation Makes News
  
• Report Suggests Ways to Manage Calories When Eating Away from Home
  
• Reports: GSK may bid $15B for Pfizer's health-care business
  
• Jury Chosen for Next Vioxx Trial in N.J.
  
• Genentech, Amgen Working On 'Cell Suicide' Drug
  
• FDA Panel Backs Bristol-Myers Leukemia Drug
  
• Book review: America lags on the superhighway
  
• Amgen says anemia drug works best with IV iron
  
• Amgen drug slows bone loss in cancer patients
  
• Unintended consequences of caps on Medicare drug benefits.
  
• Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients.
  
• Multidetector computed tomography for acute pulmonary embolism.
  
• Chronic Kidney Disease and Mortality Risk: A Systematic Review.
  
• Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study.
  
• Body-mass index and symptoms of gastroesophageal reflux in women.
  
• DaVita announces disaster hotline is 1-800-400-8331
  
• UC Davis lining up transplants for kidney patients from Kaiser
  

Clinical Nephrology

• UC Davis lining up transplants for kidney patients from Kaiser
  
• Diet changes can improve diabetic kidney function
  
• Study Identifies Barriers to Kidney Donations
  
• Program helps patients find kidneys
  
• The Cell Of Origin Of Clear Cell Renal Carcinoma - Revisited- AUA ...
  
• Lemonade vs. kidney stones
  
• Lemonade Offers Sweet Relief From Kidney Stones
  
• Kidney unit in Powys by March says health boss
  
• Kidney Cancer Patients Fare Worse if They Require Transfusions ...
  
• GPs advised to be more sensitive to abnormal renal function
  
• Ceres golfer Adrian Campos battles kidney disease
  
• AUA: Quaffing Lemonade Reduces Kidney Stone Recurrence
  
• AUA 2006 - Renal Cryoablation: 5 Year Outcomes.
  
• SAN FRANCISCO Kidney hot line set up by Kaiser
  
• Emergency surgery on a kidney saved Clifton's Mike Vinciguerra
  
• Kaiser Halts Kidney Venture
  
• Gambro acquires Sweden's Hemapure renal care access products firm
  
• Feeling 'great,' boy thanks teacher who gave him her kidney
  
• Doctor Has New Method To Break Up Kidney Stones
  
• Calif. to Oversee Kaiser Kidney Program
  

Medicare and Policy

• Medtronic official asks doctors to speak up on Medicare cuts
  
• Keryx Says 43% Of Patients Enrolled In Phase 2 Trial Of Perifosine ...
  
• UC Davis lining up transplants for kidney patients from Kaiser
  
• Medicare pay-for-performance plan complicated, AGH doctor says
  
• Study Identifies Barriers to Kidney Donations
  
• Program helps patients find kidneys
  
• New VA clinic, dialysis center in French Camp
  
• Indigenous artists stage London sale for dialysis project
  
• National: Doctors group will lobby against two-tier system
  
• DaVita Terminates Alliance And Product Supply Deal With Gambro
  

Financial

• Glaxo says lung cancer vaccine study encouraging
  
• Glaxo HPV vaccine shows promise for women 26-55
  
• Keryx Says 43% Of Patients Enrolled In Phase 2 Trial Of Perifosine ...
  
• Reports: GSK may bid $15B for Pfizer's health-care business
  
• Jury Chosen for Next Vioxx Trial in N.J.
  
• Genentech, Amgen Working On 'Cell Suicide' Drug
  
• FDA Panel Backs Bristol-Myers Leukemia Drug
  
• Amgen says test does not flag panitumumab response
  
• Amgen says anemia drug works best with IV iron
  
• Amgen drug slows bone loss in cancer patients
  
• Vioxx Study Doctors to Publish New Data
  
• Merck issues correction on Vioxx study
  
• DaVita Terminates Alliance And Product Supply Deal With Gambro
  
• Genzyme Releases Two New Molecular Tests for Acute Myelogenous Leukemia
  
• Amgen, Genentech face ever-more competitive market in cancer
  
• Amgen Shares Look Cheap Ahead Of ASCO
  
• Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy.
  
• Merck cancer vaccine faces Christian-right scrutiny
  
• Vioxx stroke risk could last years: health expert
  
• U.S. to Investigate Amgen Patent Claims
  

Pharma

• Online Course Will Offer Insight on How Gender Influences Health
  
• FDA Allows Withdrawn MS Drug Tysabri to Be Marketed Again With Restrictions
  
• MIV Therapeutics' Breakthrough Vascular Stent Coating Technology Receives Key Independent Endorsement in New Scientific Study; Independent Research Confirms Primary Safety and Biocompatibility Attributes of Company's Patented HAp Coatings
  
• Report Suggests Ways to Manage Calories When Eating Away from Home
  
• FDA Issues Warning Letters to Marketers of Unapproved "Alternative Hormone Therapies"
  
• FDA Issues Warning Letter to West Virginia Business Offering Illegal Foreign Drugs
  
• FDA Expands Warning About "Green Hornet" To Include All Other Products By Cytotec Solutions, Inc.
  
• Remicade Approved for Children with Crohn's Disease
  
• FDA Will Allow Health Claim on Barley Products
  
• FDA Announces Medical Device Innovation Initiative
  

Science

• Transgenic drug gets the go-ahead in Europe
  
• Senior sperm have dodgier DNA
  
• Green research base to be built in Antarctic
  
• Baby's first microbes sized up
  
• Sexual desire traced to genetics
  
• Polar core is hot stuff
  
• Old tools shed light on hobbit origins
  
• New Orleans: a geologists story
  
• Greenhouse gas breeds venomous vines
  
• The next wave of the web
  
• Stomach bug makes food yield more calories
  
• Promise of drug-free dinners for India's vultures
  
• Only 5% of tropical forests managed sustainably
  
• Invisibility cloaks are in sight
  
• HIV-like virus found in wild chimps
  

Technology

• Genentech, OSI say drug combo prolongs survival
  
• MIV Therapeutics' Breakthrough Vascular Stent Coating Technology Receives Key Independent Endorsement in New Scientific Study; Independent Research Confirms Primary Safety and Biocompatibility Attributes of Company's Patented HAp Coatings
  
• Genentech: Calm And Cool Under Fire
  
• Genentech, Amgen Working On 'Cell Suicide' Drug
  
• Multidetector computed tomography for acute pulmonary embolism.
  
• Amgen, Genentech face ever-more competitive market in cancer
  
• The next wave of the web
  
• Internet searches: Librarians do it better
  
• Computer-based screening helps spot domestic abuse
  
• Internet Diabetes Self-Management
  

Medicine

• Young kids with diabetes do well with insulin pump
  
• Yoga study shows some benefits for cancer patients
  
• US OKs resumed sales of Biogen and Elan's Tysabri
  
• Scheduled naps reduce fatigue in young docs
  
• Regular exercise OK for kids with type 1 diabetes
  
• Premature babies at hyperactivity risk: study
  
• More antipsychotics being prescribed for children
  
• Ill effects of inactivity reversible with exercise
  
• Glaxo says lung cancer vaccine study encouraging
  
• Glaxo HPV vaccine shows promise for women 26-55